 |
 |
|
5 April 2005 | Volume 142 Issue 7 | Pages 497-505
Background: Previous studies that evaluated the association of kidney function with incident heart failure may be limited by the insensitivity of serum creatinine concentration for detecting abnormal kidney function.
Objective: To compare serum concentrations of cystatin C (a novel marker of kidney function) and creatinine as predictors of incident heart failure.
Design: Observational study based on measurement of serum cystatin C from frozen sera obtained at the 1992–1993 visit of the Cardiovascular Health Study. Follow-up occurred every 6 months.
Setting: Adults 65 years of age or older from 4 communities in the United States.
Participants: 4384 persons without previous heart failure who had measurements of serum cystatin C and serum creatinine.
Measurements: Incident heart failure.
Results: The mean (±SD) serum concentrations of cystatin C and creatinine were 82 ± 25 nmol/L (1.10 ± 0.33 mg/L) and 89 ± 34 µmol/L (1.01 ± 0.39 mg/dL), respectively. During a median follow-up of 8.3 years (maximum, 9.1 years), 763 (17%) participants developed heart failure. After adjustment for demographic factors, traditional and novel cardiovascular risk factors, cardiovascular disease status, and medication use, sequential quintiles of cystatin C concentration were associated with a stepwise increased risk for heart failure in Cox proportional hazards models (hazard ratios, 1.0 [reference], 1.30 [95% CI, 0.96 to 1.75], 1.44 [CI, 1.07 to 1.94], 1.58 [CI, 1.18 to 2.12], and 2.16 [CI, 1.61 to 2.91]). In contrast, quintiles of serum creatinine concentration were not associated with risk for heart failure in adjusted analysis (hazard ratios, 1.0 [reference], 0.77 [CI, 0.59 to 1.01], 0.85 [CI, 0.64 to 1.13], 0.97 [CI, 0.72 to 1.29], and 1.14 [CI, 0.87 to 1.49]).
Limitations: The mechanism by which cystatin C concentration predicts risk for heart failure remains unclear.
Conclusions: The cystatin C concentration is an independent risk factor for heart failure in older adults and appears to provide a better measure of risk assessment than the serum creatinine concentration.
*For a full list of participating Cardiovascular Health Study investigators and institutions, see http://www.chs-nhlbi.org.
Editors' Notes
Context
Contribution
Implications
–The Editors
Author and Article Information
From Tufts-New England Medical Center, Boston, Massachusetts; Collaborative Health Studies Coordinating Center and University of Washington, Seattle, Washington; Amgen, Inc., Thousand Oaks, and Veterans Affairs Medical Center and University of California, San Francisco, California; University of Pittsburgh School of Medicine, Veterans Affairs Pittsburgh Healthcare System, and University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania; and University of Vermont, Burlington, Vermont.
Grant Support: Drs. Shlipak, Fried, and Katz are funded by grant R01 HL073208-01 (to Dr. Shlipak) from the National Heart, Lung, and Blood Institute. Dr. Shlipak is also supported by the American Federation for Aging Research and National Institute on Aging (Paul Beeson Scholars Program) and the Robert Wood Johnson Foundation (Generalist Faculty Scholars Program). Dr. Sarnak is supported by grant K23 DK67303 from the National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Fried is funded by an Advanced Research Career Development award from the Office of Research and Development, Medical Service, of the Department of Veterans Affairs. The Cardiovascular Health Study is supported by contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, and N01 HC-15103 from the National Heart, Lung, and Blood Institute.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Michael G. Shlipak, MD, MPH, Veterans Affairs Medical Center (111A1), 4150 Clement Street, San Francisco, CA 94121; e-mail, shlip{at}itsa.ucsf.edu.
Current Author Addresses: Dr. Sarnak: Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, NEMC 391, Boston, MA 02111.
Dr. Katz: Collaborative Health Studies Coordinating Center, University of Washington, Box 354922, Building 29, Suite 310, 6200 NE 74th Street, Seattle, WA 98115.
Dr. Stehman-Breen: Amgen, Inc., 1 Amgen Center Drive, Mailstop 38-3-C, Thousand Oaks, CA 91320.
Dr. Fried: Veterans Affairs Pittsburgh Healthcare System, University Drive, 111F-U, Pittsburgh, PA 15240.
Dr. Swords Jenny: Department of Pathology, College of Medicine, University of Vermont, Colchester Research Facility, 208 South Park Drive, Suite 2, Colchester, VT 05446.
Drs. Psaty and Siscovick: Medicine and Epidemiology, University of Washington, Cardiovascular Health Research Unit, 1730 Minor Avenue, Suite 1360, Seattle, WA 98101-1448.
Dr. Newman: Healthy Aging Research Program, Bellefield Professional Building, 130 North Bellefield Avenue, Room 532, Pittsburgh, PA 15213.
Dr. Shlipak: Veterans Affairs Medical Center (111A1), 4150 Clement Street, San Francisco, CA 94121.
Author Contributions: Conception and design: M.J. Sarnak, R. Katz, C.O. Stehman-Breen, L.F. Fried, B.M. Psaty, D. Siscovick, M.G. Shlipak.
Analysis and interpretation of the data: M.J. Sarnak, R. Katz, C.O. Stehman-Breen, D. Siscovick, M.G. Shlipak.
Drafting of the article: M.J. Sarnak, R. Katz, C.O. Stehman-Breen, D. Siscovick, M.G. Shlipak.
Critical revision of the article for important intellectual content: M.J. Sarnak, R. Katz, C.O. Stehman-Breen, L.F. Fried, N.S. Jenny, B.M. Psaty, A.B. Newman, D. Siscovick, M.G. Shlipak.
Final approval of the article: M.J. Sarnak, R. Katz, C.O. Stehman-Breen, L.F. Fried, B.M. Psaty, A.B. Newman, D. Siscovick, M.G. Shlipak.
Provision of study materials or patients: B.M. Patsy, A.B. Newman, D. Siscovick.
Statistical expertise: R. Katz, B.M. Psaty.
Obtaining of funding: M.G. Shlipak, B.M. Psaty.
Administrative, technical, or logistic support: C.O. Stehman-Breen, N.S. Jenny, A.B. Newman.
Collection and assembly of data: R. Katz, B.M. Psaty, A.B. Newman. ARTICLE
Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  B. E. K. Klein, M. D. Knudtson, P. Brazy, K. E. Lee, and R. Klein Cystatin C, Other Markers of Kidney Disease, and Incidence of Age-Related Cataract Arch Ophthalmol, December 1, 2008; 126(12): 1724 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. de Simone, J. S. Gottdiener, M. Chinali, and M. S. Maurer Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur. Heart J., March 2, 2008; 29(6): 741 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Ix, R. Katz, B. Kestenbaum, L. F. Fried, H. Kramer, C. Stehman-Breen, and M. G. Shlipak Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification J. Am. Soc. Nephrol., March 1, 2008; 19(3): 579 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.D. Giles, P.B. Rylance, and D.C. Crothers New results from the Modification of Diet in Renal Disease study: the importance of clinical outcomes in test strategies for early chronic kidney disease QJM, February 1, 2008; 101(2): 155 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sarnak, R. Katz, L. F. Fried, D. Siscovick, B. Kestenbaum, S. Seliger, D. Rifkin, R. Tracy, A. B. Newman, M. G. Shlipak, et al. Cystatin C and Aging Success Arch Intern Med, January 28, 2008; 168(2): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease Ann Intern Med, July 3, 2007; 147(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann Chronic Kidney Disease: Effects on the Cardiovascular System Circulation, July 3, 2007; 116(1): 85 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Donahue, S. Stranges, K. Rejman, L. B. Rafalson, J. Dmochowski, and M. Trevisan Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study Diabetes Care, July 1, 2007; 30(7): 1724 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Singh, M. A. Whooley, J. H. Ix, S. Ali, and M. G. Shlipak Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1087 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kottgen, S. D. Russell, L. R. Loehr, C. M. Crainiceanu, W. D. Rosamond, P. P. Chang, L. E. Chambless, and J. Coresh Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1307 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Ix, M. G. Shlipak, G. M. Chertow, and M. A. Whooley Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study Circulation, January 16, 2007; 115(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Fried, M. L. Biggs, M. G. Shlipak, S. Seliger, B. Kestenbaum, C. Stehman-Breen, M. Sarnak, D. Siscovick, T. Harris, J. Cauley, et al. Association of Kidney Function with Incident Hip Fracture in Older Adults J. Am. Soc. Nephrol., January 1, 2007; 18(1): 282 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, K. Bjorklund-Bodegard, L. Lind, J. Arnlov, and J. Sundstrom Congestive Heart Failure and Diurnal Blood Pressure Pattern--Reply JAMA, December 20, 2006; 296(23): 2800 - 2800. [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Brosius III, T. H. Hostetter, E. Kelepouris, M. M. Mitsnefes, S. M. Moe, M. A. Moore, S. Pennathur, G. L. Smith, and P. W.F. Wilson REPRINT Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease: A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation Hypertension, October 1, 2006; 48(4): 751 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wattanakit, J. Coresh, P. Muntner, J. Marsh, and A. R. Folsom Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Brosius III, T. H. Hostetter, E. Kelepouris, M. M. Mitsnefes, S. M. Moe, M. A. Moore, S. Pennathur, G. L. Smith, and P. W.F. Wilson Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease: A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation Circulation, September 5, 2006; 114(10): 1083 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, R. Katz, M. J. Sarnak, L. F. Fried, A. B. Newman, C. Stehman-Breen, S. L. Seliger, B. Kestenbaum, B. Psaty, R. P. Tracy, et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease Ann Intern Med, August 15, 2006; 145(4): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bibbins-Domingo, G. M. Chertow, L. F. Fried, M. C. Odden, A. B. Newman, S. B. Kritchevsky, T. B. Harris, S. Satterfield, S. R. Cummings, and M. G. Shlipak Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study. Arch Intern Med, July 10, 2006; 166(13): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jaffe, L. Babuin, and F. S. Apple Biomarkers in Acute Cardiac Disease: The Present and the Future J. Am. Coll. Cardiol., July 4, 2006; 48(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey Assessing kidney function--measured and estimated glomerular filtration rate. N. Engl. J. Med., June 8, 2006; 354(23): 2473 - 2483. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Smith, J. H. Lichtman, M. B. Bracken, M. G. Shlipak, C. O. Phillips, P. DiCapua, and H. M. Krumholz Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1987 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, C. L. W. Fyr, G. M. Chertow, T. B. Harris, S. B. Kritchevsky, F. A. Tylavsky, S. Satterfield, S. R. Cummings, A. B. Newman, and L. F. Fried Cystatin C and Mortality Risk in the Elderly: The Health, Aging, and Body Composition Study J. Am. Soc. Nephrol., January 1, 2006; 17(1): 254 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. O'Hare, A. B. Newman, R. Katz, L. F. Fried, C. O. Stehman-Breen, S. L. Seliger, D. S. Siscovick, and M. G. Shlipak Cystatin C and Incident Peripheral Arterial Disease Events in the Elderly: Results From the Cardiovascular Health Study Arch Intern Med, December 12, 2005; 165(22): 2666 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Fried, R. Katz, M. J. Sarnak, M. G. Shlipak, P. H.M. Chaves, N. S. Jenny, C. Stehman-Breen, D. Gillen, A. J. Bleyer, C. Hirsch, et al. Kidney Function as a Predictor of Noncardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3728 - 3735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shlipak and C. Stehman-Breen Observational Research Databases in Renal Disease J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3477 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Cystatin C Level Predicts Heart Failure in Elders Journal Watch Cardiology, April 29, 2005; 2005(429): 2 - 2. [Full Text]
|
|
|
|
 |
|
 A. Tonks What's new in the other general journals BMJ, April 23, 2005; 330(7497): 927 - 928. [Full Text] [PDF]
|
|
|
|
|
|
A. Levin Cystatin C, Serum Creatinine, and Estimates of Kidney Function: Searching for Better Measures of Kidney Function and Cardiovascular Risk Ann Intern Med, April 5, 2005; 142(7): 586 - 588. [Full Text] [PDF]
|
|
Read all Rapid Responses
Article
